Plexium
is a California-based biotechnology company that develops a platform that provides targeted protein degradation therapies for the treatment of cancer... Read morePlexium
is a California-based biotechnology company that develops a platform that provides targeted protein degradation therapies for the treatment of cancer... Read more
News
Apr 02, 2025
PR Newswire
Press Release: Plexium : Plexium Announces Two Oral Presentations and Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
Jul 25, 2024
Contract Pharma
Plexium: Xavo Welcomes Plexium as Its Latest Client
Jul 24, 2024
B3C Group
Press Release: Plexium : Plexium Selects Xavo as their Sample Management Lab Operations Platform
Jan 16, 2024
Yahoo
Plexium: Plexium Announces Appointment of Michael Martin, Ph.D. as President and CEO
Jul 13, 2022
socalTECH
Plexium: Plexium Names New Board Member
Jul 13, 2022
Markets Insider
Plexium: PLEXIUM APPOINTS BRIAN WONG, M.D., PH.D., TO ITS BOARD OF DIRECTORS
Apr 28, 2022
BioSpace
Plexium: Abbvie and Plexium Enter Into Multi-Target Strategic Collaboration To Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions
Apr 06, 2022
Markets Insider
Plexium: Plexium Announces Participation of its CEO, Percival Barretto-Ko, at Longwood Healthcare Leaders Spring MIT Webconference
Feb 28, 2022
FinSMEs
Plexium: Plexium Raises $102M Financing
Feb 24, 2022
BioCentury
Plexium: Fresh off Amgen deal, Plexium raises $102M for degrader platform
